DOTA-MGS5, a New Cholecystokinin-2 Receptor-Targeting Peptide Analog with an Optimized Targeting Profile for Theranostic Use-Reference-Cited by-同舟云学术

DOTA-MGS5, a New Cholecystokinin-2 Receptor-Targeting Peptide Analog with an Optimized Targeting Profile for Theranostic Use

Published:2018-12-07 Issue:7 Volume:60 Page:1010-1016
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Klingler Maximilian,Summer Dominik,Rangger Christine,Haubner Roland,Foster Julie,Sosabowski Jane,Decristoforo Clemens,Virgolini Irene,von Guggenberg Elisabeth

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference28 articles.

1. Cholecystokinin(CCK)-A and CCK-B/gastrin receptors in human tumors;Reubi;Cancer Res.,1997

2. Characterization of a novel five-transmembrane domain cholecystokinin-2 receptor splice variant identified in human tumors

3. Management of treatment-related toxicities in advanced medullary thyroid cancer;Brose;Cancer Treat Rev.,2018

4. Improved tumour detection by gastrin receptor scintigraphy in patients with metastasised medullary thyroid carcinoma

5. Added value of gastrin receptor scintigraphy in comparison to somatostatin receptor scintigraphy in patients with carcinoids and other neuroendocrine tumours

Cited by 42 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Fundamentals and recent advances in the evaluation and management of medullary thyroid carcinoma;Molecular and Cellular Endocrinology;2024-10

2. Cholecystokinin-2 receptor targeting by [68Ga]Ga-DOTA-MGS5 PET/CT in a patient with extensive disease small cell lung cancer;European Journal of Nuclear Medicine and Molecular Imaging;2024-05-14

3. Advances in Radioligand Theranostics in Oncology;Molecular Diagnosis & Therapy;2024-03-31

4. Significant reduction of activity retention in the kidneys via optimized linker sequences in radiohybrid-based minigastrin analogs;EJNMMI Research;2024-03-02

5. Carrier systems of radiopharmaceuticals and the application in cancer therapy;Cell Death Discovery;2024-01-09